Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Federal Circuit Affirms Fee Award to Takeda
- Aaron F. Barkoff submits: Takeda v. Mylan and Alphapharm, Nos. 2007-1269, -1270 (Fed. Cir. 2008) In an opinion released Monday, the Federal Circuit affirmed a district court decision granting $16.8 million for attorney fees, expenses and expert fees to Takeda (TKPHF.PK) for baseless paragraph IV certification letters...
- External links 2008-12-09
- Federal Circuit Affirms Extension of Stay Against Teva's Generic Evista
- Aaron F. Barkoff submits: Eli Lilly & Co. LLY v. Teva Pharms. TEVA USA, Inc., No. 2009–1071 (Fed. Cir. 2009) Under the Hatch-Waxman Act, final FDA approval of an ANDA is automatically stayed for thirty months when a patent owner files suit for patent infringement within 45 days of...
- External links 2009-02-25
- Supreme Court Denies Aventis' Cert Petition in Lovenox Case
- Aaron F. Barkoff submits: Aventis Pharma v. Amphastar and Teva, S. Ct. Appeal No. 08-937 (2009) The Supreme Court on Monday denied Aventis Pharma's SNY cert petition in a long-running dispute with generic biopharmaceutical manufacturer Amphastar. In its petition, Aventis had asked the Court to review...
- External links 2009-04-28
- Bayer Patent on Yasmin Affirmed Invalid
- Aaron F. Barkoff submits: Bayer Schering v. Barr Labs, No. 2008-1282 (Fed. Cir. 2009) A divided panel of the Federal Circuit affirmed a district court decision holding Bayer's (BYERF.PK) U.S. Patent No. 6,787,531 invalid due to obviousness. The '531 patent, which claims pharmaceutical compositions of drospirenone and ethinyl...
- External links 2009-08-06
Additional Resources
- District Court Affirms Dismissal of Prasco's Declaratory Judgment Suit Against Medicis
- Aaron F. Barkoff submits: Prasco v. Medicis Pharm. Corp., No. 2007-1524 (Fed. Cir. 2008) Medicis markets a benzoyl peroxide cleansing product, Triaz. Prasco sells a competing benzoyl peroxide cleansing product, Oscion. Prasco filed a declaratory judgment complaint, requesting judgment that Oscion does not infringe four patents owned or licensed by Medicis...
- External links 2008-10-07
- Federal Circuit Affirms Merck?s Victory in Trusopt/Cosopt Case
- Aaron F. Barkoff submits: Merck & Co. v. Apotex, No. 2008-1133 (Fed. Cir. 2008) In 2005, Hi-Tech Pharmacal HITK became the first company to file a paragraph IV certification relating to Merck's MRK glaucoma drugs Trusopt and Cosopt. Hi-Tech filed paragraph IV certifications with respect to all three...
- External links 2008-10-10
- << Previous
- page 1 of 1
- Next >>
